Beyondspring logo

Beyondspring Share Price (NASDAQ: BYSI)

$1.73

-0.07

(-3.89%)

Last updated on

Check the interactive Beyondspring Stock chart to analyse performance

Beyondspring stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$1.73
    Today's High:$1.80

    Day's Volatility :3.62%

  • 52 Weeks Low:$0.98
    52 Weeks High:$3.44

    52 Weeks Volatility :71.51%

Beyondspring Stock Returns

PeriodBeyondspring IncSector (Health Care)Index (Russel 2000)
3 Months
6.13%
3.6%
0.0%
6 Months
2.98%
-7.7%
0.0%
1 Year
-10.36%
-12.6%
0.0%
3 Years
36.22%
9.5%
-4.7%

Beyondspring Inc Key Stats

Check Beyondspring key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.8
Open
$1.795
Today's High
$1.795
Today's Low
$1.73
Market Capitalization
$72.6M
Today's Volume
$9.9K
52 Week High
$3.44
52 Week Low
$0.98
Revenue TTM
$1.9M
EBITDA
$-8.4M
Earnings Per Share (EPS)
$-0.2
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-310.48%

Stock Returns calculator for Beyondspring Stock including INR - Dollar returns

The Beyondspring stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Beyondspring investment value today

Current value as on today

₹90,088

Returns

₹9,912

(-9.91%)

Returns from Beyondspring Stock

₹15,196 (-15.2%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Beyondspring Stock

-83%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Beyondspring Stock from India on INDmoney has decreased by -83% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Beyondspring Inc

  • Name

    Holdings %

  • Decheng Capital LLC

    11.24%

  • Vanguard Group Inc

    1.30%

  • BlackRock Inc

    0.55%

  • UBS Group AG

    0.10%

  • Tanaka Capital Management Inc

    0.07%

  • Geode Capital Management, LLC

    0.06%

Analyst Recommendation on Beyondspring Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Beyondspring(by analysts ranked 0 to 5 stars)

Beyondspring Share Price Target

What analysts predicted

Downside of 27.75%

Target:

$1.25

Current:

$1.73

Beyondspring share price target is $1.25, a slight Downside of 27.75% compared to current price of $1.73 as per analysts' prediction.

Beyondspring Stock Insights

  • Price Movement

    In the last 1 month, BYSI stock has moved down by -14.8%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 500.0K → -1.43M (in $), with an average decrease of 387.6% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 4.47M → -1.80M (in $), with an average decrease of 140.3% per quarter
  • BYSI vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 85.1%
  • BYSI vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 82.5%
  • Price to Sales

    ForBYSI every $1 of sales, investors are willing to pay $36.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Beyondspring Technicals Summary

Sell

Neutral

Buy

Beyondspring is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Beyondspring Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Beyondspring Inc logo
-15.61%
2.98%
-10.36%
36.22%
-85.81%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Beyondspring Inc

BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on the development of cancer therapies. It operates through two segments: Plinabulin pipeline and TPD platform. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia. It is also developing Plinabulin in combination with docetaxel vs. docetaxel alone for the treatment of NSCLC and epidermal growth factor receptor wild type. In addition, the company develops Plinabulin in combination with various immuno-oncology agents and chemotherapy and radiation; nivolumab, a PD-1 antibody that is has completed phase 1 clinical trials for the treatment of non-small cell lung cancer; ipilimumab, a CTLA-4 antibody for the treatment of extensive-stage small cell lung cancer; in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers; and pembrolizumab, etoposide, and platinum to treat extensive-stage small cell lung cancer. Further, it engages in the development of three small molecule immune agents in preclinical stages; and a drug discovery platform to develop therapeutic agents from internal research and development efforts and from collaboration. The company was founded in 2010 and is headquartered in Florham Park, New Jersey.
Organization
Beyondspring
Employees
40
CEO
Dr. Lan Huang Ph.D.
Industry
Health Technology

Key Management of Beyondspring Inc

NameTitle
Dr. Lan Huang Ph.D.
Co-Founder, Chairman & CEO
Dr. June Lu Ph.D.
Chief Scientific Officer
Stephen Kilmer
Head of Investor Relations

Important FAQs about investing in BYSI Stock from India :

What is Beyondspring share price today?

Beyondspring share price today is $1.73 as on at the close of the market. Beyondspring share today touched a day high of $1.80 and a low of $1.73.

What is the 52 week high and 52 week low for Beyondspring share?

Beyondspring share touched a 52 week high of $3.44 and a 52 week low of $0.98. Beyondspring stock price today i.e. is closed at $1.73, lower by 49.71% versus the 52 week high.

How to invest in Beyondspring Stock (BYSI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Beyondspring on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Beyondspring Shares that will get you 0.8671 shares as per Beyondspring share price of $1.73 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Beyondspring Stock (BYSI) from India?

Indian investors can start investing in Beyondspring (BYSI) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Beyondspring stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Beyondspring share’s latest price of $1.73 as on August 30, 2025 at 1:29 am IST, you will get 5.7803 shares of Beyondspring. Learn more about fractional shares .

What are the returns that Beyondspring has given to Indian investors in the last 5 years?

Beyondspring stock has given -85.81% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?